Anivamersen sodium
The REG1 anticoagulation system consists of pegnivacogin, an RNA aptamer inhibiting coagulation factor IXa, and its complementary reversal agent anivamersen. This system has been evaluated in clinical trials for controlled anticoagulation, supporting research in thrombosis and interventional cardiology.
Product Specifications
CAS Number
959716-31-5
Field of Research
Metabolism Research
Molecular Formula
C157H194N56Na14O103P14
Molecular Weight
5269.1
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog